Dark Forest Capital Management LP Esperion Therapeutics, Inc. Transaction History

Dark Forest Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.46 - $7.3 $87 - $438	60 New	60 $0
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $2,550 - $3,804	468 Added 570.73%	550 $4,000
Q2 2022 Aug 15, 2022	BUY	$4.77 - $6.67 $391 - $546	82 New	82 $1,000
Q4 2021 Feb 11, 2022	SELL	$4.81 - $11.92 $2,866 - $7,104	-596 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$11.34 - $21.37 $4,399 - $8,291	-388 Reduced 39.43%	596 $7,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $19,089 - $28,250	984 New	984 $21,000

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $156M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.